Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

NCT04790253 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.

NCT NCT04790253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04790253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Phase
Not applicable
Overall status
Recruiting
Start date
October 27, 2022
Completion date
April 30, 2028
Enrollment
600 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

extensive-stage small-cell lung cancer, limited stage small cell lung cancer